Skip to main content
. 2021 Aug 13;7(8):657. doi: 10.3390/jof7080657

Table 3.

The patterns and methods of pulmonary cryptococcosis diagnosis.

CrAg Test of Blood, n (%) N = 321
Not performed 18 (5.6)
Yes 303 (94.4)
  Positive *   250 (82.5)
  Negative   53 (17.5)
Culture and identification of species, n (%) N = 321
Not performed 167 (52.0)
Yes 154 (48.0)
  Cerebrospinal fluid (CSF), total/positive $   110/13
  Tissue, total/positive   62/17
  Bronchoalveolar lavage, total/positive   21/13
  Sputum, total/positive   19/4
  Blood, total/positive   13/8
  Pleural effusion, total/positive   2/0
  Urine, total/positive   1/1
Identifiable culture results (n = 47)
   Cryptococcus neoformans   46 (97.9)
   Cryptococcus gattii   1 (2.1)
Biopsy and pathology, n (%) N = 321
Not performed 186 (57.9)
Yes 135 (42.1)
  Surgical biopsy, total/positive   64/64
  Computed-tomography-guided biopsy, total/positive   28/24
  Bronchoscopy, total/positive #   23/7
  Ultrasound-guided biopsy, total/positive   20/12
Lumbar puncture, n (%) N = 321
Not performed 211 (65.7)
Yes 110 (34.3)
  CrAg test of CSF negative   92 (83.6)
  CrAg test of CSF positive $   18 (16.4)

CrAg, cryptococcal antigen. * Denotes the percentage of positivity among patients with serology tests (median 1:32 (range 1:2 to 1:8192)). # Includes bronchoscopic biopsy, brush, and/or lavage. $ All 18 patients with a positive CSF CrAg test also had positive results in the blood; all 13 patients with positive CSF culture were also positive for the CSF CrAg test.